Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia.

Reumatol Clin

Department of Internal Medicine, Hospital Universitari Val d'Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain.

Published: November 2021

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160056PMC
http://dx.doi.org/10.1016/j.reuma.2020.03.001DOI Listing

Publication Analysis

Top Keywords

choose cyclosporin
4
cyclosporin first-line
4
first-line therapy
4
therapy covid-19
4
covid-19 pneumonia
4
choose
1
first-line
1
therapy
1
covid-19
1
pneumonia
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!